Viatris xanax sales revenue market share?

Xanax is a Pfizer brand name for alprazolam. Viatris does not own Xanax; it sells generic alprazolam as part of its generic portfolio. Because Xanax is a Pfizer brand, Viatris’ revenue isn’t reported separately as “Xanax,” and the company does not publish a single, official market-share figure for Viatris specifically on alprazolam.

If you want current numbers, I can look up:
- Viatris’ latest annual report/10-K or quarterly results to identify any disclosed alprazolam (or “alprazolam tablets”) sales within their generic portfolio.
- Independent market data (e.g., IQVIA) for Viatris’ share of the global or U.S. alprazolam market.

Please tell me:
- Geography (global vs. U.S. market)
- Timeframe (latest calendar year, trailing twelve months, or a specific year)

I can then pull and summarize the relevant figures. If you’d like, I can start by locating Viatris’ latest filings and any available market data.